[Risk and benefits of hormone replacement therapy by postmenopausal women. WHI-Study].
Heinemann
V
V
Medizinische Klinik II, Grosshadern, Klinikum der Ludwig-Maximilians-Universität München. Volker.Heinemann@med3.med.uni-muenchen.de
Parhofer
K
K
D000368:Aged; D001943:Breast Neoplasms / Q000139:chemically induced / Q000453:epidemiology* / Q000517:prevention & control; D015179:Colorectal Neoplasms / Q000453:epidemiology*; D003327:Coronary Disease / Q000139:chemically induced / Q000453:epidemiology*; D016889:Endometrial Neoplasms / Q000453:epidemiology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000401:mortality; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D050723:Fractures, Bone / Q000453:epidemiology / Q000517:prevention & control; D020249:Hormone Replacement Therapy / Q000009:adverse effects* / Q000401:mortality; D006801:Humans; D015994:Incidence; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology; D017698:Postmenopause / Q000187:drug effects; D045167:Progesterone Congeners / Q000009:adverse effects / Q000627:therapeutic use*; D016016:Proportional Hazards Models; D011655:Pulmonary Embolism / Q000453:epidemiology; D018570:Risk Assessment / Q000379:methods; D020521:Stroke / Q000453:epidemiology; D016019:Survival Analysis; D013927:Thrombosis / Q000453:epidemiology; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D016387:Women's Health
D004966:Estrogens, Conjugated (USP); D045167:Progesterone Congeners; D017258:Medroxyprogesterone Acetate